Press Releases

June 22-2026 – TETmedical Receives FDA Breakthrough Device Designation for NSE-FAST

September 22-2026 – TETmedical Strengthens Board of Directors with Appointment of Marc Lebel and Patrick McBrayer

September 29-2026 – TETmedical Names Arjun Ishwar Chief Commercial Officer to Lead Commercial Strategy and Accelerate NSE-FAST® Toward Market Launch and Rapid Growth